Reteplase
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Reteplase, covering 2023-09-14 to 2026-03-30. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Human Urinary Kallidinogenase Combined With Reteplase Intravenous Thrombolysis in the Treatment of Acute Ischemic Stroke [NA]